How big is the Endocrinology Drugs Market?

The Endocrinology Drugs Market size is expected to reach USD 101.60 billion in 2024 and grow at a CAGR of 6.09% to reach USD 136.60 billion by 2029. Read More

What is the current Endocrinology Drugs Market size?

In 2024, the Endocrinology Drugs Market size is expected to reach USD 101.60 billion. Read More

Who are the key players in Endocrinology Drugs Market?

AbbVie Inc, AstraZeneca Plc, Novartis AG, Novo Nordisk A/S and Eli Lilly and Company are the major companies operating in the Endocrinology Drugs Market. Read More

Which is the fastest growing region in Endocrinology Drugs Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Endocrinology Drugs Market?

In 2024, the North America accounts for the largest market share in Endocrinology Drugs Market. Read More

What years does this Endocrinology Drugs Market cover, and what was the market size in 2023?

In 2023, the Endocrinology Drugs Market size was estimated at USD 95.41 billion. The report covers the Endocrinology Drugs Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Endocrinology Drugs Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Endocrinology Drugs Market Share

Statistics for the 2023 & 2024 Endocrinology Drugs market share, created by Mordor Intelligence™ Industry Reports. Endocrinology Drugs share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Endocrinology Drugs Industry

The endocrinology drugs market is fragmented in nature due to the presence of several companies operating globally. The major players include AbbVie Inc., AstraZeneca PLC, Novartis AG, Eli Lilly and Company, Merck KGaA, Novo Nordisk A/S, Sanofi, and Takeda Pharmaceutical Company Limited.